{"paper_id":"1a13c0d8-0f51-4c34-9309-092c32ff3a4a","body_text":"Citation: Sannamma H J (2025). Endometriosis: Evolving Management Approaches. Saudi J Nurs Health Care, 8(9): 241-243. \n \n  241 \n \n \n \nSaudi Journal of Nursing and Health Care \nAbbreviated Key Title: Saudi J Nurs Health Care \nISSN 2616-7921 (Print) | ISSN 2616-6186 (Online) \nScholars Middle East Publishers, Dubai, United Arab Emirates \nJournal homepage: https://saudijournals.com  \n \n Review Article \n \nEndometriosis: Evolving Management Approaches \nSannamma H J1* \n \n1Assistant Professor, Government College of Nursing, Vijayapur \n \nDOI: https://doi.org/10.36348/sjnhc.2025.v08i09.005    | Received: 17.07.2025 | Accepted: 15.09.2025 | Published: 22.09.2025 \n \n*Corresponding author: Sannamma H J \nAssistant Professor, Government College of Nursing, Vijayapur \n \nAbstract  \n \nEndometriosis is a chronic, estrogen -dependent inflammatory disorder that affects nearly 10% of individuals of \nreproductive age worldwide. It is associated with severe pelvic pain, infertility, and profound psychosocial burden. Despite \nthe absence of a def initive cure, recent evidence underscores the importance of prevention, early intervention, and \ncomprehensive management. Strategies such as lifestyle modification, dietary interventions, hormonal suppression, and \nearly diagnostic practices have shown pote ntial in reducing disease incidence, severity, and recurrence. This review \nintegrates current insights into pathophysiology, preventive measures, systemic effects, infertility, and therapeutic \napproaches, highlighting the need for a holistic, multidiscipli nary framework spanning primary, secondary, and tertiary \nprevention. \nKeywords: Endometriosis; Pathophysiology; Prevention; Infertility; Mental health; Multidisciplinary management; \nPrecision medicine; Recurrence. \nCopyright © 2025 The Author(s): This is an open -access article distributed under the terms of the Creative Commons Attribution 4.0 International \nLicense (CC BY-NC 4.0) which permits unrestricted use, distribution, and reproduction in any medium for non -commercial use provided the original \nauthor and source are credited. \n \nINTRODUCTION \nEndometriosis is defined by the presence of \nendometrial-like tissue outside the uterine cavity, \ntriggering inflammation, adhesions, and chronic pain, \noften culminating in infertility. Beyond reproductive \nhealth, it exerts systemic impacts, including \ngastrointestinal dysfunction, mood disorders, and \nelevated cardiovascular risks. Since curative therapies \nremain elusive, preventive and multidisciplinary \nstrategies are increasingly emphasized to mitigate \ndisease progression and improve quality of life. \n \nEtiologic Insights and Risk Factors \nMultiple genetic, hormonal, and environmental \ninfluences contribute to disease onset. \n• Reproductive and hormonal factors:  Early \nmenarche, short cycles, nulliparity, and low BMI \nincrease susceptibility. \n• Genetic predisposition:  Family history elevates \nrisk by six- to nine-fold. \n• Congenital anomalies:  Reproductive tract \nmalformations predispose to retrograde flow. \n• Environmental influences:  Endocrine-disrupting \nchemicals are emerging as potential contributors, \nthough causality remains under investigation. \n \n \n \nPathophysiology \nEndometriosis arises from interconnected biological \nprocesses: \n• Retrograde menstruation vs. stem cell theory:  \nSampson’s classic model explains peritoneal \nlesions, whereas stem cell theory accounts for \nextrapelvic disease via progenitor cells. \n• Immune dysfunction:  Aberrant macrophages, \ncytokine overexpression (IL -1β, TNF -α), and \nimpaired NK-cell activity facilitate lesion survival. \n• Hormonal imbalance:  Estrogen dominance and \nprogesterone resistance perpetuate inflammation \nand cellular proliferation. \n• Genetics and epigenetics:  GWAS highlight loci \nsuch as WNT4, GREB1, and VEZT; epigenetic \ndysregulation (DNA methylation, miRNA \nalterations) modifies immune and endocrine \npathways. \n• Gut microbiome:  Dysbiosis alters estrogen \nmetabolism and systemic inflammation, providing a \nnovel pathogenic perspective. \n \nPreventive Strategies \nPrimary Prevention – Delaying Onset and Reducing Risk \n• Lifestyle modification:  Regular physical activity \nand smoking cessation reduce risk. \n• Dietary measures: \no Omega-3 fatty acids lower risk by ~22%. \n\n\n \n \nSannamma H J, Saudi J Nurs Health Care, Sep, 2025; 8(9): 241-243 \n© 2025 | Published by Scholars Middle East Publishers, Dubai, United Arab Emirates                                                                                   242 \n \n \no Diets rich in antioxidants (vitamins C, D, E) \nmay alleviate symptoms. \no High intake of red/processed meat increases \nrisk, whereas dairy intake appears protective. \n• Hormonal modulation:  Continuous hormonal \ncontraceptives suppress retrograde menstruation. \n• Reproductive factors:  Pregnancy and lactation \nconfer temporary protective effects. \n \nSecondary Prevention – Early Detection and Control \n• Awareness and education:  Early recognition of \nsevere dysmenorrhea, especially in adolescents and \nthose with family history. \n• Imaging advances:  Transvaginal ultrasound and \nMRI are recommended as first-line diagnostic tools. \n• Biomarkers: Circulating miRNAs and liquid \nbiopsies are under development for early disease \ndetection. \n \nTertiary Prevention – Reducing Recurrence and \nOptimizing Quality of Life \n• Post-surgical suppression:  Prolonged hormonal \ntherapy reduces recurrence rates. \n• Fertility preservation:  Oocyte and ovarian tissue \ncryopreservation are vital for women at high risk. \n• Self-care strategies: A low-FODMAP diet relieves \ngastrointestinal symptoms in many patients. \n• Psychological support:  Cognitive-behavioral \ntherapy (CBT) and mindfulness improve coping and \nquality of life. \n \nEndometriosis and Infertility \nInfertility affects 30 –50% of affected women. \nMechanisms include pelvic adhesions, defective \nfolliculogenesis, impaired implantation, and altered \nendometrial receptivity. \n• Impact on ART outcomes: Severe disease reduces \noocyte yield and pregnancy rates. \n• Recent advances: \no Personalized ovarian stimulation minimizes \niatrogenic damage. \no AI-driven embryo selection improves \nimplantation prediction. \no Fertility preservation before repeat surgeries is \nincreasingly advocated. \n \nMental Health Considerations \nThe chronic pain and reproductive challenges of \nendometriosis heighten vulnerability to depression, \nanxiety, OCD, and even suicidality. \n• Biological mechanisms:  Pain-induced HPA axis \ndisruption leads to neurotransmitter imbalance. \n• Emerging evidence (2024 –25): Pre-pregnancy \nendometriosis correlates with increased postpartum \npsychiatric disorders. \n• Clinical implications:  Routine integration of \nmental health screening and interventions is \nessential within gynecological practice. \n \nEndometriosis as a Systemic Condition \nEndometriosis extends beyond gynecology, \ninfluencing multiple organ systems: \n• Cardiovascular: Increased risk of hypertension, \nstroke, and atherosclerosis. \n• Autoimmune: Strong associations with thyroid \ndisease, lupus, and rheumatoid arthritis. \n• Gastrointestinal: IBS-like symptoms are frequent. \n• Musculoskeletal: Fatigue syndromes and \nfibromyalgia often overlap. \n \nCurrent and Emerging Management Approaches \nMedical Therapy \n• Hormonal therapy: Combined oral contraceptives, \nprogestins, GnRH antagonists. \n• Pain control: NSAIDs and multimodal regimens. \n \nSurgical Options \n• Laparoscopic or robotic -assisted excision for \nsymptom relief and fertility improvement. \n• High recurrence rates remain a challenge. \n \nEmerging Therapies \n• Immunomodulators and biologics:  Anti-TNF and \nIL-6 inhibitors. \n• Non-hormonal agents:  Angiogenesis inhibitors \nand epigenetic modulators. \n• Precision models:  Patient-derived organoids for \nindividualized drug testing. \n \nPsychological and Nursing Interventions \n• Counseling, CBT, mindfulness -based stress \nreduction, and peer support groups. \n• Nurses play pivotal roles in education, adherence \nsupport, and lifestyle guidance. \n \nFuture Perspectives \nThe future of endometriosis care lies in: \n• Genomic and biomarker-driven precision medicine. \n• Non-invasive diagnostics (AI -assisted imaging, \nliquid biopsy). \n• Integration of reproductive and mental health \nservices. \n• Multidisciplinary care models uniting gynecology, \npsychiatry, endocrinology, and nursing. \n• A strong emphasis on prevention to reduce global \ndisease burden. \n \nCONCLUSION \nEndometriosis is increasingly recognized as a \ncomplex systemic condition rather than a localized pelvic \ndisease. Effective management demands preventive, \nholistic, and multidisciplinary strategies. Lifestyle and \ndietary interventions, early detection, and recurrence \nprevention—combined with precision medicine and \nmental health integration—offer the most promising path \nforward in reducing morbidity, infertility, and \npsychosocial distress associated with the disease. \n \n\n \n \nSannamma H J, Saudi J Nurs Health Care, Sep, 2025; 8(9): 241-243 \n© 2025 | Published by Scholars Middle East Publishers, Dubai, United Arab Emirates                                                                                   243 \n \n \nREFERENCES \n• Zondervan KT, Becker CM, Missmer SA. \nEndometriosis. N Engl J Med.  2020;382(13):1244–\n1256. \n• Chapron C, Marcellin L, Borghese B, Santulli P. \nRethinking mechanisms, diagnosis and management \nof endometriosis. Nat Rev Endocrinol.  \n2019;15(11):666–682. \n• Bulun SE, Yilmaz BD, Sison C, et al. , \nEndometriosis. Endocr Rev. 2019;40(4):1048–1079. \n• Vannuccini S, Clemenza S, Rossi M, et al.,  \nInfertility and endometriosis: new insights into \npathogenesis and treatment. Reprod Biomed Online. \n2022;44(4):589–601. \n• Smolarz B, Szyłło K, Romanowicz H. \nEndometriosis: epidemiology, classification, \npathogenesis, treatment and genetics. Int J Mol Sci.  \n2021;22(19):10554. \n• Zondervan KT, Becker CM. Endometriosis and \nmental health: novel insights. Lancet Psychiatry.  \n2024;11(1):14–26. \n• Shigesi N, Kvaskoff M, Kirtley S, et al.,  The \nassociation between endometriosis and autoimmune \ndiseases: a systematic review and meta -analysis. \nHum Reprod Update. 2019;25(4):486–503. \n• Evans MB, Decherney AH. Fertility and \nendometriosis. Clin Obstet Gynecol. 2021;64(1):52–\n63. \n• Leone Roberti Maggiore U, Ferrero S, Mangili G, et \nal., Endometriosis: pathogenesis, diagnosis, therapy \nand association with cancer. Obstet Gynecol Surv.  \n2016;71(7):413–432. \n• Guo SW. Recurrence of endometriosis and its \ncontrol. Hum Reprod Update. 2009;15(4):441–461.","source_license":"CC0","license_restricted":false}